Axsome stock tumbled Tuesday after Axsome Therapeutics issued mixed results for its drug, Sunosi, in ADHD treatment.

Axsome Therapeutics' experimental drug to treat attention deficit hyperactivity disorder (ADHD) helped improve symptoms of the developmental disorder in adults, it said on Tuesday, meeting the main ...

Axsome Therapeutics said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met its main goal in a late-stage study. The drug, solriamfetol, helped ease symptoms ...

Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...

Investing.com -- Shares of Axsome Therapeutics (NASDAQ: AXSM) fell 5.5% following the announcement of its phase 3 trial results for Solriamfetol in adults with ADHD, which achieved its primary ...

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in developing and delivering novel therapies for the management of central nervous system (CNS) disorders in the United States.

In this article, we are going to take a look at where Axsome Therapeutics, Inc. (NASDAQ:AXSM) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

Meeting to be held in New York on March 18 at 6 pm hosted by Truist. Light Up your Portfolio with Spark:Easily identify stocks' risks and ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings firms that are covering the stock, MarketBeat Ratings reports.

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps ...

The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by HC Wainwright & Co. on March 6, 2025. The analyst firm set a price target for $200.00 expecting AXSM to rise to within ...

In this article, we are going to take a look at where Axsome Therapeutics, Inc. (NASDAQ:AXSM) stands against the other biotech stocks. No matter the market environment, you’ll always find ...